Puma Biotechnology Has a Simple Plan to Get Back to Growth

Puma Biotechnology Has a Simple Plan to Get Back to Growth

Source: 
Motley Fool
snippet: 

Investors knew ahead of the Nov. 6 arrival of Puma Biotechnology's (NASDAQ:PBYI) third-quarter update that the report was going to be an important one. The question on everyone's mind was pretty straightforward: Had the company been able to do anything to address physicians' waning enthusiasm for its only drug product?